Statistics of high-throughput sequencing and variant calling. Table S2. Somatic mutations detected by high-throughput sequencing in 76 cases of primary DLBCL. (XLSX 384Â kb
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
Table S1. Variant allele frequency (VAF) of somatic mutations in both cases. (DOCX 24Â kb
Table S1. Mutation profiles of BLS genes in colorectal, melanoma, gastric, and uterine cancers. Tabl...
Clinico-pathological features of the discovery set - pure LCIS. Table S1b. Clinico-pathological feat...
Abstract Background/purpose Recently, the mutational background of diffuse large B cell lymphoma (DL...
Clinical characteristics and survival rate of patients with localized PG-DLBCL. It shows the clinica...
Comparison between mutations detected by conventional Sanger sequencing and Deep sequencing and esti...
Table S1. List of target genes sequenced by targeted deep sequencing. Table S2. Mutations in Exposed...
Regimens of chemotherapy. Table S2. Univariate analysis of the factors affecting CR in DLBCL and BL ...
Table S1. Genomic analysis of pre-treatment tumor in complete responder with DLBCL. Table S2. Periph...
All supplementary tables merged. 1: List of all identified SiMPRes. 2: All novel genes that contain ...
Table S1. 3-year survival data and classification. Table S2. Comparison of gene somatic mutation rat...
Figure S1. Rates and types of BLS alterations across human tumor datasets. A) cBioportal was utilize...
Clinical and treatment characteristics of the 18 cases with no ctDNA alterations detected. Table S2....
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
Table S1. Variant allele frequency (VAF) of somatic mutations in both cases. (DOCX 24Â kb
Table S1. Mutation profiles of BLS genes in colorectal, melanoma, gastric, and uterine cancers. Tabl...
Clinico-pathological features of the discovery set - pure LCIS. Table S1b. Clinico-pathological feat...
Abstract Background/purpose Recently, the mutational background of diffuse large B cell lymphoma (DL...
Clinical characteristics and survival rate of patients with localized PG-DLBCL. It shows the clinica...
Comparison between mutations detected by conventional Sanger sequencing and Deep sequencing and esti...
Table S1. List of target genes sequenced by targeted deep sequencing. Table S2. Mutations in Exposed...
Regimens of chemotherapy. Table S2. Univariate analysis of the factors affecting CR in DLBCL and BL ...
Table S1. Genomic analysis of pre-treatment tumor in complete responder with DLBCL. Table S2. Periph...
All supplementary tables merged. 1: List of all identified SiMPRes. 2: All novel genes that contain ...
Table S1. 3-year survival data and classification. Table S2. Comparison of gene somatic mutation rat...
Figure S1. Rates and types of BLS alterations across human tumor datasets. A) cBioportal was utilize...
Clinical and treatment characteristics of the 18 cases with no ctDNA alterations detected. Table S2....
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
Table S1. Variant allele frequency (VAF) of somatic mutations in both cases. (DOCX 24Â kb